Welcome to kongre.net

TI

SummitIn person

9th TPD & Induced Proximity Summit

Hosted by Hanson Wade

26 – 29 October 2026
Add to calendar
Apple / Outlook (.ics)Google Calendar
Welcome to kongre.net
Events Categories News
The Omni Boston Hotel at the Seaport, Boston, United States of America
Health SciencesPharmacy & Pharmaceutical Sciences

Let others know you'll be there. This does not register you for the event.

Welcome to kongre.net

Welcome to kongre.net

Official website

Programme

Published

56 sessions across 4 days

3 rooms · 60 speakers

Browse programme

Registration

Registration is handled by the organiser

Fees are listed on this page

View registration details

Key facts

9th TPD & Induced Proximity Summit is a summit held 26 – 29 October 2026 in The Omni Boston Hotel at the Seaport, Boston, United States of America, organised by Hanson Wade.

Dates:: 26 – 29 October 2026
Format:: In person
Venue:: The Omni Boston Hotel at the Seaport, Boston, United States of America
Subjects:: Pharmacy & Pharmaceutical Sciences
Organiser:: Hanson Wade
Official website:: proteindegradation.com

The 9th TPD & Induced Proximity Summit is the world's definitive forum dedicated to targeted protein degradation and induced proximity drugs. Organised by Hanson Wade, the event takes place from October 26-29, 2026, at The Omni Boston Hotel at the Seaport in Boston, MA. Gathering over 350 attendees and 80+ world-class speakers from academia, start-ups, biotechs, and pharma, the summit connects the full TPD ecosystem across four days of deep scientific exploration spanning early discovery to clinical development.

Programme highlights

View full programme

Mon, 26 Oct 2026Chair’s Opening RemarksPlenary12 sessions this day
Tue, 27 Oct 2026Chair’s Opening RemarksPlenary11 sessions this day
Wed, 28 Oct 2026Chair’s Opening RemarksPlenary13 sessions this day

Keynote speakers

Keynote
Stuart Schreiber
Professor, Harvard Medical School
Principles Underlying Induced Proximity Drugs: Lessons from Early Development to the Present
Keynote
Randy Teel
President & Chief Executive Officer, Arvinas, Inc.
Degradation Delivered – What the First TPD Approval Means for the Future of the Field

Speakers

View all 62 speakers

Gisele NIshiguchi
St. Jude Children's Research Hospital
Discovery of a Potent & Selective Molecular Glue Degrader of PPIL4 Active in Pediatric Acute Leukemia & Medulloblastoma
Giovanni Spagnolli
Sibylla Biotech srl
Inducing the Selective Degradation of Cyclin D1 by Interfering with its Folding Pathway
Jonathan Gilbert
Eli Lilly & Co.
Discussion: Harnessing AI & Computational Modelling to Optimize Design, Specificity & Efficacy of Induced Proximity Molecules to Support the Development of Tolerable, Selective Therapies
Chunhai Hao
Degrome Therapeutics
Molecular Glue Degraders Enhance CAPRIN1-Dependent Lysosomal Degradation of APP & Reduce Amyloid in Alzheimer’s Disease
Peter Ung
Genentech
Optimizing the Next Generation Degraders with Better Informatics, Descriptors & Predictive Modeling +1 more
Takashi Sugane
Astellas Pharma
Optimizing Novel Heterobifunctional Degraders – An Update
Adrian Gottschalk
Foghorn Therapeutics
Panel Discussion: Navigating the Evolving Induced Proximity Landscape: Trends, Opportunities & Global Impact
Nicki Thompson
Trimtech Therapeutics
Expanding the Degrader Toolbox for Neuro Applications

Venue & travel The Omni Boston Hotel at the SeaportBoston, United States of AmericaVenue details About the organiser Hanson Wade4 more events from this organiserOrganiser profile Who is going? See who is planning to attend and say you are goingSee who is going

Organiser and contact

Host organisation

Hanson Wade 4 more events from Hanson Wade

Contact

Event secretary:: Stacey Millard
Email:: [email protected]

Advertisement

Related events